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Abstract
Background: The biological justification for the choice of the genetic mode in genetic association studies (GAS) is
seldom available. Then, the mode of inheritance is approximated by investigating a number of non-orthogonal
genetic contrasts making the interpretation of results difficult.
Methods: We propose to define the mode of inheritance by the significance of the deviance of the co-dominant
contrast and the degree of dominance (h), which is a function of two orthogonal contrasts (the co-dominant and
additive). Non-dominance exists when the co-dominant contrast is non-significant and, hence, the risk effect of
heterozygotes lies in the middle of the risk of the two homozygotes. Otherwise, dominance (including over- and
under-dominance) is present and the direction of dominance depends on the value of h.
Results: Simulations show that h may capture the real mode of inheritance and it is affected by deviations from
Hardy-Weinberg equilibrium (HWE). In addition, power for detecting significance of h when the study conforms to
HWE rule increases with the degree of dominance and to some extent is related to the mutant allele frequency.
Conclusion: The introduction of the degree of dominance provides useful insights into the mode of
inheritance in GAS.
Background
Genetic association studies (GAS), candidate-gene and
genome-wide association studies assess the association
between a disease and genetic variants (gene poly-
morphisms) in a population [1]. For a bi-allelic candi-
date gene with alleles wild-type wt and mutant-type mt
in a case-control study, where mt is thought to be asso-
ciated with a disease, the association is usually assessed
using a chi-squared test for the 3 × 2 contingency table
with genotype entries n11(wtwt), n21(wtmt)a n dn31
(mtmt) for the control subjects, and n12(wtwt), n22
(wtmt)a n dn32(mtmt)f o rt h ed i s e a s e ds u b j e c t s[ 2 ] .
However, besides evaluating the overall statistical signifi-
cance, the clinical relevance of a genetic association
depends on the magnitude of risk conferred to the car-
riers of allele mt [3]. Thus, in view of a significant asso-
ciation, the following contrasts of genotypes are defined
by merging information of the genotype distribution [4],
and estimated with the odds ratio (OR) and its 95% con-
fidence interval (CI): (i) the additive contrast, which is
defined as the comparison between the extreme geno-
types -mtmt vs. wtwt- (in this contrast the heterozygotes
are ignored. Note that this contrast does not correspond
to the conventionally examined “additive model” which
is tested using the Armitage’s test for trend [5]); (ii) the
recessive contrast, which compares genotype mtmt with
the merged genotypes wtwt +wtmt; (iii) the dominant
contrast, which merges genotypes mtmt + wtmt and
compares them with genotype wtwt; and (iv) the co-
dominant contrast, which compares genotype wtmt
against the merged genotypes mtmt + wtwt [1].
The biological justification for the choice of the genetic
contrasts (which may not necessarily present the genetic
model of inheritance) to be tested is, however, seldom
available and lack of ap r i o r iassumption for the specific
genetic model is customary practice [6,7]. This actually
translates to investigating all four models above in GAS,
and the interpretation of results may be confusing; that
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even all of them are statistically significant [1]. The
obvious reason for this is because in a case-control 3 × 2
contingency table there are only 2 degrees of freedom
(i.e., there are two independent contrasts at most) and,
therefore, the previous contrasts are not statistically inde-
pendent. Furthermore, when a large number of compari-
sons are made following a significant genotype effect,
some of the contrasts might be significant due to a type I
error.
In this paper, we propose an index (h)t h a tm e a s u r e s
the degree of dominance and allows inferring the mode
of inheritance in GAS in a continuous scale. Then, we
numerically analyze how the h-index performs by using
of a population genetics model where the real mode of
inheritance can be defined ap r i o r i , and provide esti-
mates of power. We also investigate how deviations
from Hardy-Weinberg equilibrium (HWE) can affect
inferences of the mode of inheritance using the h-index.
Finally, we illustrate the method with an empirical study
of published GAS.
Methods
Contrast definition and model analysis
Consider a GAS of a bi-allelic polymorphism which
evaluates the risk associated with allele mt.T h eg e n o -
type frequencies are given in a 3 × 2 contingency table
with counts
Genotype Controls Cases
wt/wt n11 n12
wt/mt n21 n22
mt/mt n31 n32
(1)
To analyze this case-control study, the following logit
model can be fitted to the dataset
log
π
1 − π

= β0 + β1 × g , (2)
where π is the probability of being diseased, and g is
the genotype effect with 3 levels. Then, the deviance
due to the genotype effect (Dg) in the model determines
significance of g, and the significance test is based on
the c
2-distributionwith 2 degrees of freedom (dfg) [8].
Let us now define the additive and the co-dominant
contrasts [1]. The additive model(La) presents an indivi-
dual contrast (comparison) between the two extreme
homozygotes (with a single degree of freedom: dfLa =1)
La =

icigi;c =[10−1];

ici =0 , (3)
and gi is the effect due to the ith genotype (i =1 ,2 ,3 )
[9]. The magnitude of the association corresponding to
this contrast is estimated by the natural logarithm(ln) of
the odds ratio θa =( n32 × n11)/(n12 × n31) (i.e., we refer
to an additive contrast on the ln-scale). The estimator
ln(θa) is approximately normally-distributed with asymp-
totic variance Var

ln(θa)

=

1
n32
+
1
n11
+
1
n12
+
1
n31
	
[10]. Statistical significance of the additive contrast can
be tested using a z-test z =l n (θa)


Var

ln(θa)

.
The co-dominant model (L∞) is the individual contrast
between the heterozygotes and the average of the two
homozygotes (with dfLco =1)
Lco =

icigi,
c =[−0.5 1 −0.5];

ici =0 . (4)
The magnitude of the association for this contrast is
estimated as the natural logarithm of the odds ratio
θco =
n22 × (n11 + n31)
n21 × (n12 + n32)
, with asymptotic variance
Var

ln(θco)

=

1
n22
+
1
n11 + n31
+
1
n21
+
1
n12 + n32
	
.S t a -
tistical significance can also be tested using a z-test as
above. The additive and co-dominant contrasts are clearly
orthogonal because the dot product of the ci coefficients
defining each contrast is zero (i.e., [1 0 -1]·[-0.5 1 -0.5] =
0) [9].
These statistically orthogonal contrasts can be inter-
preted separately since the deviance of the genotype
effect can be split into two independent deviances: one
due to the additive contrast

DLa

and the other due to
the co-dominant contrast

DLco

[8,9]. In other words,
Dg = DLa + DLco,a n ddfg = dfLa + dfLco.N o wt h el o g i t
model (2) is equivalent to the model
log
π
1 − π

= β0 + β1 × La + β1 × Lco. (5)
Testing the significance of the genotype effect is thus
equivalent to simultaneously testing the significance of
the additive and co-dominant contrasts based on the
respective deviances or z-tests.
Modelling the disease inheritance
We define here for a GAS showing a significant statisti-
cal association (i.e., showing significance for at least one
of the two orthogonal contrasts) the model of disease
inheritance according to the degree of dominance h of
the mutant allele mt. In the extreme case where there is
non-dominance (i.e., co-dominance or perfect additiv-
ity), the heterozygote wtmt “lies” exactly in the middle
of the two homozygotes, with mtmt having the maxi-
mum susceptibility of being diseased and wtwt having
t h el e a s t( F i g u r e1 ) .T h ed e v i a n c ef o rt h ec o - d o m i n a n t
contrast

DLco

is then non-significant, whereas the
deviance

DLa

for the additive contrast is expected to
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cant association. On the other hand, significance of DLco
indicates dominance (i.e., the heterozygote wtmt lies
towards mtmt or wtmt) irrespectively of the significant
level of DLa.
We can use now the odds ratios of the co-dominant
and additive contrasts to define the magnitude and the
direction of the degree of dominance. Deviation from
perfect additivity can result in dominance (the heterozy-
gote deviates from the middle of the two homozygotes),
over-dominance (the heterozygote has a greater risk of
disease than the homozygote mtmt), or under-domi-
nance (the heterozygote has least risk for the disease
than the homozygote wtwt) (Figure 1). Therefore, the
degree of dominance could be derived from the ratio of
the logarithms of the two previous odds ratios as
h =
ln(θco)
| ln(θa) |
, (6)
where “|| ” denotes absolute value. In expression (6)
the sign of ln(θco) determines the direction of domi-
nance, and the value of ln(θco) relative to the absolute
value of ln(θa) the magnitude of dominance deviation h,
which can take any value from negative infinity to posi-
tive infinity (Figure 2).
Once significance in dominance is detected and h is
obtained, the degree of dominance is inferred as follows
(assuming, of course, that homozygote mtmt has higher
disease risk than homozygote wtwt) (Figures 1 and 2). If
-1 ≤ h < 0 there is dominance of the wild-type allele wt,
and the heterozygote wtwt is expected to have a risk of
being diseased somewhere in between the middle of the
Risk for
disease
mtmt
Protection
for disease
wtwt wtmt
co-dominance
(h = 0) (a)
wtwt
or
wtmt wtmt
Risk for
disease
Protection
for disease
dominance
(–1  h  1
and h  0 )
mtmt
(b)
Risk for
disease
Protection
for disease
wtmt mtmt wtwt
over-dominance
(h > 1 )
(c)
wtmt mtmt wtwt
Risk for
disease
Protection
for disease
under-dominance
(h < –1 ) (d)
Figure 1 Degree of dominance h is a function of the deviation in risk of disease of the heterozygote wtmt from the co-dominant model, in
which the heterozygote is expected to lay exactly in the middle of the two homozygotes (a). Dominance deviation can be positive or negative
(b), with the heterozygote closer to the risk-exposed homozygote mtmt (0 <h ≤ 1), or to the risk-protected homozygote wtwt (-1 ≤ h < 0). Over-
dominance (c) arises when the risk of disease of the heterozygote is higher than that of the risk-exposed homozygote (h > 1), whereas under-
dominance (d) arises when the risk of disease of the heterozygote is lower than that of the risk-protected homozygote (h <- 1 ) .
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I f0< h ≤ 1 there is dominance of the mutant allele mt
and the heterozygote wtmt is expected to have a risk of
being diseased somewhere in between the middle of the
two homozygotes and towards to the homozygote mtmt.
When h > 1 there is over-dominance and the heterozy-
gote has a higher risk of being diseased than the homo-
zygote mtmt,w h e r e a si fh < -1 there is under-
dominance and the heterozygous has least chance of
being diseased than the homozygote wtwt. However,
over- and under- dominance is a rare phenomenon in
GAS [6].
The statistical test to asses the significance of over- or
under-dominance -that is, to test the null hypothesis H0:
h=1vs.H a: h > 1 (over-dominance), or vs.H a: h <- 1
(under-dominance) is equivalent to test:
i) H0: k =l n

θco
θα
	
=0 vs. H1: k =l n

θco
θα
	
>0
(over-dominance) or H1: k =l n

θco
θα
	
<0 (under-domi-
nance) when ln(θa)>0 ,
ii) H0: k =l n ( θco × θa)=0v s .H1: k =l n ( θco × θa)>0
(over-dominance) or H1: k =l n ( θco × θa)<0( u n d e r -
dominance) when ln(θa)<0 .
This can be done using a one-sided z-t e s tw h e r et h e
variance of k is approximately
Var (k) =V a r

ln(θco)

+V a r

ln(θα)

×

1 −
2
π
	
,
where (1-2/π) is arising from the variance of a half-
normal distribution [11]. When the test is non-signifi-
cant we conclude that there is just dominance or that
over-/under-dominance is not beyond chance.”
To summarize, inferences regarding any degree of
dominance h are obtained from the following order of
hypothesis. The first hypothesis states that there is non-
dominance, and is tested using the co-dominant con-
trast. If this hypothesis is true, the risk of disease for the
heterozygote wtmt is in the middle of the two homozy-
gotes. If the co-dominant contrast is significant, we then
test for the direction of dominance by stating the second
hypothesis; that is, 0 < |h| ≤ 1. If this hypothesis is true,
the heterozygote wtmt has a risk of disease closer to the
homozygote mtmt or the homozygote wtwt according to
the sign (+ or -, respectively) of h. Finally, if this hypoth-
esis is false we assess whether or not there is significant
over- or under-dominance by testing the hypothesis |h|
> 1 using k.
Results
We suggest the use of h as defined in (6) to infer the
mode of inheritance in GAS, but an obvious question is:
how does this index perform? Here, we check (i) the
performance of h when the real genetic model is known
in advance from a standard population genetics model,
then we analyze (ii) power from computer simulations
by randomly exploring the parameter space, 0.2 ≤ h ≤
1.0 (-0.2 ≥ h ≥ -1.0) in case-control studies, and (iii) the
impact that deviations from HWE in the control sub-
jects have on the h index.
Performance of the h index
We make use of a standard one-locus, two-allele model
in population genetics that generalizes the role played
by the real degree of dominance (H) on the evolution of
a deleterious mutant allele (mt) in a population [12] to
 f
–1 1 0
f
Dominance allele 
wt
Dominance allele 
mt
Under-dominance Over-dominance
N
o
n
-
d
o
m
i
n
a
n
c
e
Degree of dominance h
Figure 2 Snapshot of the degree of dominance according to the sign of h in order to facilitate the interpretation of results.
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population genetics model goes as follows
Genotype Frequencies t1 Fitness Frequencies t2
wtwt p2
1 1
p2
1
¯ w
wtmt 2p1q1 1 − Hs
2p1q1 (1 − Hs)
¯ w
mtmt q2
1 1 − s
q2
1 (1 − s)
¯ w
(8)
where ¯ w = p2
1 +2 p1q1 (1 − Hs) + q2
1 (1 − s) ,a n ds is
the coefficient of selection (s > 0, i.e. s is the decrease in
fitness of homozygous carriers for the mutant allele rela-
tive to the wild-type genotype). In words, we assume
that there is an initial cohort of individuals in HWE and
that in the time interval t1®t2 there is a genotype-
dependent per capita probability of survival (relative to
the wild-type homozygote wtwt)g i v e nb yt h ev a l u e si n
the column labeled “fitness”,w i t hs >0a n d0≤ H ≤ 1;
that is, we know in advance that allele mt is associated
with an increased probability of death as time goes on.
The parameter H captures the degree of dominance of
the mutant allele, which is fully recessive when H =0 ,
co-dominant when H = 1/2, and fully dominant when H
= 1 [13]. To convert this simple model into a hypotheti-
cal case-control study we proceeded as follows.
Assume 10,000 individuals at t1 with allele frequencies
in the range 0.05 ≤ q1 ≤ 0.5, and obtain the resulting
genotype frequencies at time t2 in (8) for the whole
range of the parameter space 0 ≤ H ≤ 1( c h a n g e si nt h e
parameter s do not affect the qualitative results).
Because the “disease trait” we are studying is the geno-
type-dependent probability of death in the time interval
t1®t2, the appropriate genotype distribution of cases to
be compared with the controls (i.e., the initial cohort) is
simply that arising from the individuals that have died.
To avoid having entries with zero in the case-control
study, we assumed a constant genotype-independent
probability of death equal to 5% (this does not obviously
affect the qualitative results). This procedure allows us
to define parametric controls and cases for any type of
i n h e r i t a n c em o d e( H) and selection coefficient (s). In
order to simulate a “sampling” case-control study, n =
400/400 cases/controls subjects are sampled randomly
form the parametric cohort based on the space defined
by the cumulative genotype frequencies [e.g. if a control
subject is randomly sampled in the space from n1/(n1
+n2+n3)t o( n1+n2)/(n1+n2+n3), then the subject is
assigned as heterozygous].
Figure 3 plots index h against parameter H assuming s =
0.2 and 0.5. For very low allele frequencies (0.05 ≤ q1 ≤
0.40) there is little chance of detecting recessiveness of
allele mt (i.e., H < 0.5) because, in general, h ≥ -0.2;
whereas for relatively high allele frequencies (q1 = 0.40),
h-index can estimate more efficiently H. In any case,
h-index tends to perform better when the selection coeffi-
cient increases (i.e. the risk of disease is higher in homozy-
gous mutants).
Power
To estimate power simulations were performed by ran-
domly exploring the parameter space 0.1 ≤ h ≤ 1.0 (0.1
≥ h ≥ -1.0) in case-control studies. Genotype frequencies
ni2(i = 1, 2, 3) for the cases in (1) were randomly gener-
ated with the restriction

i
ni2 = 400 and resulting fre-
quencies for the disease-associated allele mt bounded by
0.09 ≤ qcases ≤ 0.11, 0.09 ≤ qcases ≤ 0.21, or 0.39 ≤ qcases
≤ 0.41. Genotype frequencies in the controls were gen-
erated assuming HWE (P ≥ 0.05) with the restriction 
i
ni1 = 400 and qcontrols ≤ qcases. Power to detect domi-
nance was assessed as [14]
Power =
#(P < 0.05) co - dominant contrast
# simulations
. (9)
Figure 4 shows that power increases with increasing
frequencies of allele mt, and also when h increases
(decreases) as expected. There is, however, some asym-
metry depending on allele mt being inferred to be domi-
nant (h > 0; Figure 2) or recessive (h <0 ) .W h e nmt is
recessive power to detect moderate levels of dominance
(h ≤ -0.4) is substantial even at relative low allele fre-
quencies, which might be explained due to the restric-
tions imposed to genotype frequencies.
Impact of deviations from HWE on h index
We now analyze how estimates of the degree of domi-
nance h in GAS are affected by deviations from Hardy-
Weinberg equilibrium (HWE) in the control subjects
[15]. We first present a general analytical treatment on
the topic, and then illustrate the analysis with
simulations.
Following Weir [16], genotype frequencies in the con-
trols can be modeled from (1) as n11= n￿1×( p
2+ D),
n21= n￿1×( 2 pq-2 D)a n dn31= n￿1×( q
2+ D); where
p (q = 1- p)i st h ef r e q u e n c yo fa l l e l ewt(mt), n￿1=
n11+n21+n31 is the total number of control subjects in
the study, and D

D =
n11
n•1
− p2
	
is the Hardy-Wein-
berg disequilibrium parameter which is expected to be
zero when a population has Hardy-Weinberg propor-
tions (i.e., testing for HWE is equivalent to a test of the
hypothesis H0: D = 0). Bounds on D are [17]
max

−p2,−q2
≤ D ≤ pq. (10)
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Page 5 of 12Figure 3 Performance of the h-index against the true underlying mode of inheritance given by parameter H for allele frequencies in
the range (0.05 ≤ q1 ≤ 0.4 and selection coefficient s = 0.2 and 0.50, when 400/400 controls/cases are sampled from the parametric
cohort. Each plot also gives the Spearmann correlation between H and h-index.
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written as
θa =

n32
n12
	
×

p2 + D
q2 + D
	
θco =

n22
n12 + n32
	
×

p2 + q2 +2 D
2pq − 2D
	
.
(11)
From (10) it is straightforward to estimate the impact
deviations from HWE will have in the two contrasts
(reasonably assuming p ≥ q)
n32
n12
×
p
q
≤ θa (HWE) ≤∞
∞≥θco (HWE) ≥

n22
n12 + n32
	
,
(12)
where the first terms in the inequalities are for a posi-
tive value of D (D=p q , which obviously implies that
there is an excess of homozygotes), and the last terms
are for negative values (D=- q
2, with an excess of
heterozygotes). From (12) it is now clear that population
stratification (i.e., when a sample is composed of sub-
samples that differ in allele frequencies, thus generating
and excess of homozygotes due to the well-known
Wahlund’s principle in population genetics [12]) will
generally upward bias the absolute value of h, where the
opposite is true when there is an excess of heterozygotes
in the controls.
Simulations were performed by randomly generating
subject cases with genotype frequencies ni2(i=1,2,3)
under the restriction

i
ni2 = 400 and 0.05 ≤ qcases ≤
0.40 for allele mt. Genotype frequencies in the controls
were modeled following Weir [16] as indicated above,
with the restriction qcontrols ≤ qcases and D ≥ 0.005 (D ≤
-0.005). Note that when modeled in this way we are
assuming parametric genotype frequencies in the con-
trols; that is, we assume perfect HWE in the controls
with allele frequencies equal to the simulated values.
Figure 5 illustrates the bias incurred when estimating h,
and also points to an asymmetry in the sense that within
-
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Figure 4 Plot of power versus h assuming HWE in the controls (P ≥ 0.05) for different frequencies of the mutant allele (maf).
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Page 7 of 12the range -1 ≤ h ≤ 1 studies where D < 0 could perhaps
be included without the bias being too serious (note,
however, that in some cases h changes sign), but when
D > 0 occurs we may not capture the true direction of
dominance.
We now illustrate the proposed methodology by
applying it to three working examples. Thereafter, an
empirical study using a database of 831 GAS was carried
out.
GAS with non-dominance
A GAS investigating the association between the ACE
D/I polymorphism and coronary artery disease (CAD)
produced the following genotype distributions [18]:
Genotype Controls Cases
II 64 (30.6% ) 34(16.6% )
ID 94(45.0% ) 89(43.4% )
DD 51(24.4% ) 82(40% )
After fitting the logit model (2) the change in deviance
due to the genotype effect was Dg = 16.72 with dfg =2
(P < 0.01); thus, there is significant association between
ACE D/I polymorphism and CAD. Now, we expect at
least one of the orthogonal contrasts to be significant.
When the genotype effect was split into its two indepen-
dent contrasts and the logit model was re-fitted follow-
ing equation (5), the changes in deviance were
DLa = 16.62 with dfLa =1(P <0 . 0 1 ) ,a n dDLco =0 . 1 0
with dfLco =1(P =0 . 7 5 ) ,f o rt h ea d d i t i v ea n dc o - d o m i -
nant contrasts; respectively. DLa + DLco = 16.72 as
expected because the two degrees of freedom of the
genotype effect were orthogonally decomposed into its
two genetic components. Given that DLco was not signif-
icant the data suggest that the mode of inheritance can
be non-dominance. The interpretation would then be
that the heterozygote ID has a risk of being diseased
that lies in the middle of the risk-protected II and risk-
exposed DD homozygous genotypes.
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Figure 5 Plot of the effect deviation from HWE have on h when there is excess of heterozygotes (D < 0) or an excess of homozygotes
(D > 0) in the controls. Only values in the range (-4, 4) are plotted for different frequencies of the mutant allele (maf).
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A GAS investigating the association between the alleles
ADH2*1 and ADH2*2 with alcoholism produced the fol-
lowing genotype distributions [19]:
Genotype Controls Cases
∗2

∗2 448(82.2% ) 238(70.0% )
∗2

∗1 93(17.1% ) 85(25.0% )
∗1

∗1 4(0.7% ) 17(5.0% )
The logit model with the genotype effect was fitted and
the deviances were significant for both contrasts (P <
0.01 for DLco and DLa). Because the co-dominant model
is significant, we proceed to inquiry about the degree of
dominance, which here is h =l n ( θco)/|ln(θa)| = 0.48/|
2.08| = 0.23, suggesting dominance for the risk-asso-
ciated allele *1. Therefore, we may conclude that the
homozygous *1/*1 has a greater risk of being alcoholic
than the homozygous *2/*2, and that the heterozygote
*2/*1 has a risk of alcoholism closer to the *1/*1 homozy-
gote than to the midpoint between the two homozygotes.
GAS with under-dominance
A GAS investigating the association between the BDNF
G196A polymorphism and schizophrenia produced the
following genotype distributions [20]
Genotype Controls Cases
GG 208(59.4% ) 229(71.3% )
GA 131 (37.4% ) 83 (25.9% )
AA 11 (3.1% ) 9 (2.8% )
In this last example, the co-dominant contrast was sig-
nificant (P < 0.01) whereas the deviance for the additive
contrast was not (P < 0.52). The degree of dominance is
h =l n ( θco)/|ln(θa)| = -0.54/|0.30| = -1.82, therefore there
is indication for under-dominance since h < -1. The one-
sided z-test for under-dominance (h <- 1o rk < 0or) is sta-
tistically significant (P = 0.02). Thus, it seems that the het-
erozygote GA has the least risk of disease (or higher
protection) than both homozygotes, which do not statisti-
cally differ between them.
Empirical study
A database of 831 GAS archived in the Department of
Biomathematics, University of Thessaly (http://biomath.
med.uth.gr/), was utilized for the empirical study [15]. A
GAS was considered eligible when (i) it examined bi-
allelic polymorphisms; (ii) it provided the complete gen-
otype distribution for diseased subjects and controls of
individual studies included in the meta-analysis; (iii)
controls were non-diseased; (iv) it was written in Eng-
lish; and (v) considered binary outcomes.
In 208 GAS, the genotype distribution showed a sig-
nificant association after fitting the logit model (2) with
the genotype effect. These studies involved 58 variants
from 20 genes in association with 12 phenotypes. Table 1
summarizes the inferred degree of dominance (h)i nt h e
GAS, and groups studies according to the mode of
inheritance (non-dominance, dominance, over-domi-
nance, and under-dominance), and also according to the
significant associations found for the contrasts that were
of customary used in previous analyses.
The important point here is that in most GAS (114
out of 208; i.e., 55%) the proposed method defines a
non-dominance inheritance, whereas the conventional
contrasts applied to these studies would render a statis-
tical significant dominant contrast (64 out of 114; i.e.,
56%) or recessive contrast (86 out of 114; i.e., 75%).
However, 19% (i.e., 18 out of 94) of the studies with
dominance deviated from HWE with D >0a n d2 0 %
with D < 0; and with non-dominance the values are 3%
(i.e., 3 out of 114) with D >0a n d9 %w i t hD <0 .T h e
majority of studies with non-dominance (86%) or domi-
nance (84%) were underpowered (power < 0.5); and only
6% and 5%, respectively, have power > 0.8.
Also important is that in a significant proportion of
studies (25%) our method detects under- (12%) or over-
dominance (13%). Figure 6 plots -log[P] as a function of
h for the co-dominant and the additive contrasts. Statis-
tical significance of the additive model was (with a few
exceptions) only found when under- or over-dominance
were absent.
Discussion
Herein, we have proposed to identify the mode of inheri-
t a n c ei nac o n t i n u o u ss c a l eu s i n gt h ed e g r e eo fd o m i -
nance h, which is based on the ratio of the odds ratio of
the co-dominant contrast divided by the absolute value
o ft h eo d d sr a t i oo ft h ea d d i tive contrast. Numerical
Table 1 Results from 208 GAS studies that render a statistically significant association.
Degree of dominance Total (*) Number of GAS with significant contrasts
Co-dominant Additive Dominant Recessive
Non-dominance (h = 0) 114 0 114 64 86
Dominance (h≠0) 94 94 22 59 29
Under-dominance (h < -1) 26(18) 26 1 10 9
Dominance (-1 ≤ h <0 )o r( 0< h ≤ 1) 41 41 21 34 16
Over-dominance (h > 1) 27(15) 27 0 15 4
The degree of dominance is presented. The results produced by applying the dominant and recessive contrasts are also shown.
* Studies with significant (P < 0.05) under- or over-dominance
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Page 9 of 12results suggest that the h index captures the essence of
what should be understood by genetic model or mode of
inheritance. A meticulous analysis has been performed to
check performance against an ap r i o r imodel where we
already know that a mutant allele is associated to a
disease and also the degree of dominance of this allele.
Simulations also show that the degree of dominance h is
affected by deviations from HWE, although the bias is
more serious when there is population stratification. In
these cases the findings should be interpreted carefully,
(a)
(b)
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Figure 6 Empirical behavior of the degree of dominance h from 208 GAS showing significant genotype effects. The plots show -log[P]
as a function of h for (a) the co-dominant and (b) the additive contrasts, and the horizontal line at -log[P] = 1.3 represents the critical value
above which statistical significance (P < 0.05) is attained. There is a clear reverse behaviour in the plots and, as predicted from our numerical
study, statistical significance of the additive model was found when under- or over-dominance were absent (i.e., |h| ≤ 1).
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Page 10 of 12and adjustments for departures from HWE might be
applied [1,10]. Furthermore, power for detecting signifi-
cance for h when the study conforms HWE rule increases
with the degree of dominance and to some extent is
related to the mutant allele frequency.
The empirical study we carried out showed the degree
of dominance may sufficiently indicate the mode of
inheritance. Any degree of dominance exists when the
co-dominant contrast is significant irrespectively to the
additive contrast. The co-dominant and additive con-
trasts show a reverse pattern in h and, also important,
in the range of over- or under-dominance the additive
contrast is non-significant. In general, candidate-gene
studies have a tendency to lack power for detecting
dominance arising from weak genetic contributions of
common variants; though, large genome-wide associa-
tion studies have been undertaken recently and an effort
to create consortia for data sharing is initiated [21,22].
An underpowered GAS will underestimate the signifi-
cance of the orthogonal contrasts and, therefore, the
value of h. Nevertheless, the power to detect the signifi-
cance of the co-dominant contrast and/or the additive
contrast is the same with the power to detect a signifi-
cance association between the genotype distribution and
the disease using a logistic regression with explanatory
variable the genotype with three levels. The proposed
index may be applied to both types of GAS (candidate-
gene studies and GWAS) in the same way (of course
the recording of the genotype distribution is a necessary
condition). However, in testing the significance of the
orthogonal contrasts for an individual variant of a
GWAS a multiplicity adjustment should be considered.
In order to avoid the obstacle of the multiple genetic
contrasts, Zintzaras [4] proposed the concept of general-
ized odds ratio (ORG) for analyzing and meta-analyzing
GAS. ORG is a single statistic that summarizes the mag-
nitude and significance of the association without con-
sidering the hash of possible contrasts, and provides a
straightforward interpretation of the results in GAS. The
ORG utilizes the complete genotype distribution and
provides an estimate of the magnitude of the associa-
tion, given that the mutational load and the phenotype
(bi-allelic or multi-allelic) are treated as a graded expo-
sure (case-control or disease progression). Specifically,
ORG express the probability of a subject being diseased
relative to probability of being free of disease, given that
the diseased subject has a higher mutational load than
the non-diseased. ORG with values greater than one sug-
gests that disease is proportional to increased genetic
exposure and inversely proportional for values less than
one. Thus, the application of ORG m a yo v e r c o m et h e
shortcomings of multiple model testing or erroneous
model specification and provides an alternative and
robust way for genetic association testing.
Regarding meta-analysis, model-free approaches have
been proposed to estimate the genetic model [6,23].
However, we would like to stress that merging studies
with potentially heterogeneous modes of inheritance
should be avoided since we could entirely miss the true
biological meaning underlying disease susceptibility. The
application of our proposed method to identify the
mode of inheritance warrants further investigation in
this context. Although the methodology proposed here
is straightforward, a Bayesian approach for implement-
ing the method might be more desirable, especially
when there is prior estimation of the magnitude and
accuracy of the genetic risk effect and the degree of
dominance [24,25].
Conclusion
The introduction of the degree of dominance h, which is
the ratio of the two orthogonal contrasts, may provide
useful insights into the mode of disease inheritance.
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